Week of April 8, 2019
Major indices are rocketing to near all-time highs.
All as Wall Street expects President Trump to announce the date of a trade summit with Chinese leader Xi Jinping, which is lifting investor sentiment.
“The market is certainly climbing the proverbial wall of worry,” said Jeff Zipper, managing director of investments at U.S. Bank Private Wealth Management, as quoted by CNBC. “But that said, when you look at the internals in the domestic market … you’re seeing industrial metals outperform precious metals; you’re seeing consumer discretionary outperform consumer staples. That would lead investors to believe this market still has room to grow.”
Should we see an agreement, and an end to the trade war, we wouldn’t be shocked to see Dow Jones 30,000 this year. Stay tuned.
Opportunity No. 1
Nabriva Therapeutics (NBRV)
As we near June 30, the stock could push significantly higher into an FDA decision on the company’s Contepo IV drug for the treatment of complicated urinary tract infections. If approved, it will be a first-in-class intravenous antibiotic with broad spectrum activity against Gram-negative and Gram-positive organisms, according to the Nabriva site.
Opportunity No. 2
Advanced Micro Devices (AMD)
The stock is pushing even higher now after analysts at Nomura initiated the stock with a buy rating and a $33 price target. The firm believes strong revenue growth and improving profitability can send the stock even higher.
Opportunity No. 3
Bank of America (BAC)
Bank of America (BAC) is just beginning to rebound and pivot higher after a brief pullback. We believe it could refill its recent bearish gap at $30, and potentially move to test $31, near-term. Stocks such as BAC came under pressure in mid-March 2019 after yields on the 10-year notes ran above the 3-month notes. Now, that the yield curve is sloping up again, calm is resuming, especially for banks.
When markets are as volatile as they are, sometimes it’s best to invest in long-term opportunities, as we did with the following recommendations over the last few weeks. Listed below is the stock, date, the closing price on that day and the current price.
- Editas Medicine (EDIT) – 3/15/19 – $24.29 to $26.67
- Momo Inc. (MOMO) – 3/15/19 – $38.50 to $40.10
- Nektar Therapeutics (NKTR) – 3/15/19 – $35.53 to $35.29
- Aerojet Rocketdyne Holdings (AJRD) – 3/22/19 – $33.50 to $33.91
- Marathon Oil Corporation (MRO) – 3/22/19 – $16.68 to $17.14
- Boingo Wireless Inc. (WIFI) – 3/22/19 — $22.02 to $24.35
- H&E Equipment Services (HEES) – 3/29/19 — $25.11 to $26.64
- Coca-Cola (KO) – 3/29/19 – $46.86 to $46.48
- Nike Inc. (NKE) – 3/29/19 – $84.21 to $85.28